在治疗 1 型脊髓性肌萎缩症时，选择利地普仑而不是奴西能生会不会是一个巨大的成本最小化机会？

{"title":"在治疗 1 型脊髓性肌萎缩症时，选择利地普仑而不是奴西能生会不会是一个巨大的成本最小化机会？","authors":"Andrej Belančić, Andrea Katrin Faour, Elvira Meni Maria Gkrinia, Dinko Vitezić","doi":"","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":10796,"journal":{"name":"Croatian Medical Journal","volume":"65 5","pages":"454-456"},"PeriodicalIF":1.5000,"publicationDate":"2024-10-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11568377/pdf/","citationCount":"0","resultStr":"{\"title\":\"Could choosing risdiplam instead of nusinersen in the treatment of type 1 spinal muscular atrophy be a huge cost-minimization opportunity?\",\"authors\":\"Andrej Belančić, Andrea Katrin Faour, Elvira Meni Maria Gkrinia, Dinko Vitezić\",\"doi\":\"\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":10796,\"journal\":{\"name\":\"Croatian Medical Journal\",\"volume\":\"65 5\",\"pages\":\"454-456\"},\"PeriodicalIF\":1.5000,\"publicationDate\":\"2024-10-31\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11568377/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Croatian Medical Journal\",\"FirstCategoryId\":\"92\",\"ListUrlMain\":\"\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"MEDICINE, GENERAL & INTERNAL\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Croatian Medical Journal","FirstCategoryId":"92","ListUrlMain":"","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}